DBT (dihydrolipoamide branched-chain transacylase E2) encodes an essential component of the branched-chain α-ketoacid dehydrogenase complex (Chuang et al., 2006), and its low expression in colorectal cancer inhibits the cuproptosis process. Here, DBT is linked to colorectal cancer.